The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gangappa, S.
Right arrow Articles by Rouse, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gangappa, S.
Right arrow Articles by Rouse, B. T.
The Journal of Immunology, 1998, 161: 4289-4300.
Copyright © 1998 by The American Association of Immunologists

Virus-Induced Immunoinflammatory Lesions in the Absence of Viral Antigen Recognition1

Shivaprakash Gangappa*, John Sam Babu{dagger}, Johnson Thomas*, Massoud Daheshia* and Barry T. Rouse2,*

* Department of Microbiology, University of Tennessee, Knoxville, TN 37996; {dagger} Department of Medicine/Arthritis, Northwestern University, Chicago, IL 60611

Herpetic stromal keratitis (HSK) is a CD4+ T cell-controlled immunopathologic lesion in the eye that results from infection with herpes simplex virus (HSV). Target Ags involved in HSK remain undefined. In this study, we determined if HSK could be induced in animals genetically incapable of generating HSV Ag-specific CD4+ T cells. Mice bearing transgenic TCR specific to OVA peptide 323–339 (DO11.10) were crossed to SCID mice whose offspring (Tg-SCID) possessed CD4+ T cells, >98% of which expressed the OVA peptide-specific TCR. HSV infection of Tg-SCID mice was lethal, and mice failed to generate detectable T cell responses even after repeated immunization with a mutant avirulent virus (AN-1). Immunization with AN-1 virus followed by ocular challenge with HSV resulted in ocular inflammation before encephalitis, in contrast to the protection conferred in the control BALB/c and DO11.10 mice. These results indicate that clinical HSK may not require viral Ag recognition by CD4+ T cells and that T cells of irrelevant specificity can be recruited, activated, and driven into effector function in the HSV-infected cornea. This is suggested to represent a bystander activation effect resulting from the presence of proinflammatory mediators resulting from HSV replication.




This article has been cited by other articles:


Home page
J. Virol.Home page
K. Sagou, T. Imai, H. Sagara, M. Uema, and Y. Kawaguchi
Regulation of the Catalytic Activity of Herpes Simplex Virus 1 Protein Kinase Us3 by Autophosphorylation and Its Role in Pathogenesis
J. Virol., June 1, 2009; 83(11): 5773 - 5783.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sanchez-Ruiz, L. Wilden, W. Muller, W. Stenzel, A. Brunn, H. Miletic, D. Schluter, and M. Deckert
Molecular Mimicry between Neurons and an Intracerebral Pathogen Induces a CD8 T Cell-Mediated Autoimmune Disease
J. Immunol., June 15, 2008; 180(12): 8421 - 8433.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Kim, S. Suvas, P. P. Sarangi, S. Lee, R. A. Reisfeld, and B. T. Rouse
Vascular Endothelial Growth Factor Receptor 2-Based DNA Immunization Delays Development of Herpetic Stromal Keratitis by Antiangiogenic Effects
J. Immunol., September 15, 2006; 177(6): 4122 - 4131.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. J. Lepisto, G. M. Frank, M. Xu, P. M. Stuart, and R. L. Hendricks
CD8 T Cells Mediate Transient Herpes Stromal Keratitis in CD4-Deficient Mice.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3400 - 3409.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Banerjee, P. S. Biswas, and B. T. Rouse
Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis
J. Leukoc. Biol., January 1, 2005; 77(1): 24 - 32.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Banerjee, P. S. Biswas, U. Kumaraguru, S. P. Schoenberger, and B. T. Rouse
Protective and Pathological Roles of Virus-Specific and Bystander CD8+ T Cells in Herpetic Stromal Keratitis
J. Immunol., December 15, 2004; 173(12): 7575 - 7583.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. B. McGavern and P. Truong
Rebuilding an Immune-Mediated Central Nervous System Disease: Weighing the Pathogenicity of Antigen-Specific versus Bystander T Cells
J. Immunol., October 15, 2004; 173(8): 4779 - 4790.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Xu, A. J. Lepisto, and R. L. Hendricks
CD154 Signaling Regulates the Th1 Response to Herpes Simplex Virus-1 and Inflammation in Infected Corneas
J. Immunol., July 15, 2004; 173(2): 1232 - 1239.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Curran, O. M. FitzGerald, P. J. Costello, J. M. Selby, D. J. Kane, B. Bresnihan, and R. Winchester
Nucleotide Sequencing of Psoriatic Arthritis Tissue before and during Methotrexate Administration Reveals a Complex Inflammatory T Cell Infiltrate with Very Few Clones Exhibiting Features That Suggest They Drive the Inflammatory Process by Recognizing Autoantigens
J. Immunol., February 1, 2004; 172(3): 1935 - 1944.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Lundberg, P. Welander, X. Han, and E. Cantin
Herpes Simplex Virus Type 1 DNA Is Immunostimulatory In Vitro and In Vivo
J. Virol., October 15, 2003; 77(20): 11158 - 11169.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. W. Mullins, R. S. Martins, and K. D. Elgert
Tumor-Derived Cytokines Dysregulate Macrophage Interferon-{gamma} Responsiveness and Interferon Regulatory Factor-8 Expression
Experimental Biology and Medicine, March 1, 2003; 228(3): 270 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. J. J. Carr and S. Noisakran
The Antiviral Efficacy of the Murine Alpha-1 Interferon Transgene against Ocular Herpes Simplex Virus Type 1 Requires the Presence of CD4+, {alpha}/{beta} T-Cell Receptor-Positive T Lymphocytes with the Capacity To Produce Gamma Interferon
J. Virol., August 12, 2002; 76(18): 9398 - 9406.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Zheng, D. M. Klinman, M. Gierynska, and B. T. Rouse
DNA containing CpG motifs induces angiogenesis
PNAS, June 25, 2002; 99(13): 8944 - 8949.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
M Halberstadt, M Machens, K-A Gahlenbek, M Bohnke, and J G Garweg
The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin
Br. J. Ophthalmol., June 1, 2002; 86(6): 646 - 652.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Lassmann, C. Kincaid, V. C. Asensio, and I. L. Campbell
Induction of Type 1 Immune Pathology in the Brain Following Immunization Without Central Nervous System Autoantigen in Transgenic Mice With Astrocyte-Targeted Expression of IL-12
J. Immunol., November 1, 2001; 167(9): 5485 - 5493.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Zheng, S. Deshpande, S. Lee, N. Ferrara, and B. T. Rouse
Contribution of Vascular Endothelial Growth Factor in the Neovascularization Process during the Pathogenesis of Herpetic Stromal Keratitis
J. Virol., October 15, 2001; 75(20): 9828 - 9835.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Deshpande, M. Zheng, S. Lee, K. Banerjee, S. Gangappa, U. Kumaraguru, and B. T. Rouse
Bystander Activation Involving T Lymphocytes in Herpetic Stromal Keratitis
J. Immunol., September 1, 2001; 167(5): 2902 - 2910.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Zheng, M. A. Schwarz, S. Lee, U. Kumaraguru, and B. T. Rouse
Control of Stromal Keratitis by Inhibition of Neovascularization
Am. J. Pathol., September 1, 2001; 159(3): 1021 - 1029.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. Benencia, M. C. Courrèges, G. Gamba, H. Cavalieri, and E. J. Massouh
Effect of Aminoguanidine, a Nitric Oxide Synthase Inhibitor, on Ocular Infection with Herpes Simplex Virus in Balb/c Mice
Invest. Ophthalmol. Vis. Sci., May 1, 2001; 42(6): 1277 - 1284.
[Abstract] [Full Text]


Home page
Exp. Biol. Med.Home page
D. J.J. Carr, P. Härle, and B. M. Gebhardt
The Immune Response to Ocular Herpes Simplex Virus Type 1 Infection
Experimental Biology and Medicine, May 1, 2001; 226(5): 353 - 366.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. P. Deshpande, S. Lee, M. Zheng, B. Song, D. Knipe, J. A. Kapp, and B. T. Rouse
Herpes Simplex Virus-Induced Keratitis: Evaluation of the Role of Molecular Mimicry in Lesion Pathogenesis
J. Virol., April 1, 2001; 75(7): 3077 - 3088.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. K. Eo, S. Lee, S. Chun, and B. T. Rouse
Modulation of Immunity against Herpes Simplex Virus Infection via Mucosal Genetic Transfer of Plasmid DNA Encoding Chemokines
J. Virol., January 15, 2001; 75(2): 569 - 578.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. P. Deshpande, M. Zheng, M. Daheshia, and B. T. Rouse
Pathogenesis of Herpes Simplex Virus-Induced Ocular Immunoinflammatory Lesions in B-Cell-Deficient Mice
J. Virol., April 15, 2000; 74(8): 3517 - 3524.
[Abstract] [Full Text]


Home page
IOVSHome page
S. Gangappa, S. P. Deshpande, and B. T. Rouse
Bystander Activation of CD4+ T Cells Accounts for Herpetic Ocular Lesions
Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 453 - 459.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.